CIK 0001469443
- Non-accelerated filer
- Smaller reporting company
Arcadia Biosciences, Inc.
Sign in to watch- Ticker
- RKDA
- Exchange
- Nasdaq
- Industry
- Beverages
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810571538
- Phone
- +1 214-974-8921
- Business address
- 5956 SHERRY LANE, SUITE 2000, DALLAS, TX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-03 | Reiter Sarah Chief Commercial Officer | Purchase | +700 | $1.72 | $1K | 3,800 |
| 2020-02-03 | Reiter Sarah Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 121,705 | ||
| 2019-12-23 | Reiter Sarah Chief Commercial Officer | Purchase | +900 | $5.95 | $5K | 3,100 |
| 2019-11-19 | Reiter Sarah Chief Commercial Officer | Purchase | +1,000 | $4.52 | $5K | 2,200 |
| 2019-09-10 | Reiter Sarah Chief Commercial Officer | Purchase | +1,200 | $6.48 | $8K | 1,200 |
| 2019-06-03 | Reiter Sarah Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +23,305 | 71,705 | ||
| 2018-09-18 | Reiter Sarah Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +38,400 | 48,400 | ||
| 2018-03-19 | Reiter Sarah Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 1 of 1 · 8 trades